Anatara Lifesciences Ltd (ASX:ANR) Share Price Remains Unchanged as Stock Trades at $0.009

Anjali Anand

13 August 2026 09:36 PM AEST

Anatara Lifesciences Ltd (ASX:ANR) Share Price Remains Unchanged as Stock Trades at $0.009

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Anatara Lifesciences Ltd (ASX:ANR) shares remained unchanged at $0.009 during the latest trading session.
No shares were traded during the session, with Volume recorded at zero.
The company’s Market Capitalisation stood at $2.84M based on the latest provided figures.
The stock traded between its 52-week range of $0.007 and $0.020.
Anatara Lifesciences Ltd has 315,950,765 shares on issue.

Overview

Anatara Lifesciences Ltd (ASX:ANR) is listed on the Australian Securities Exchange and operates within the healthcare sector. This article provides an educational summary of the company’s latest available share price information and market statistics based on the provided data.

The article covers available trading details, including share price, trading volume, market capitalisation, share structure and historical price range. It is intended to provide a factual overview of the company’s market information and does not represent financial advice or a recommendation regarding the company’s shares.

Share Price Movement

Shares of Anatara Lifesciences Ltd (ASX:ANR) remained unchanged at $0.009 during the latest provided trading session. The previous close was also recorded at $0.009, resulting in a daily movement of 0.000%.

No trading volume was recorded during the session, with total volume reported at 0 shares. As a result, no intraday trading range was available, with the day range recorded as “--”.

The bid and offer range was recorded between $0.009 and $0.010, representing the available quoted buying and selling levels during the reported period.

The stock’s 52-week trading range was recorded between $0.007 and $0.020. This range represents the highest and lowest prices recorded for the stock over the previous 12-month period and provides historical context for the latest available share price.

Trading Volume and Market Capitalisation

Anatara Lifesciences Ltd recorded trading volume of 0 shares during the session. Trading volume represents the number of shares exchanged between buyers and sellers during a particular trading period.

The average volume for the stock was recorded at 903,710 shares. Comparing daily trading activity with average volume provides a reference point for understanding market participation levels during the reported session.

The company’s market capitalisation was $2.84M based on the latest provided market data. Market capitalisation represents the total Market Value of a company’s Issued Shares and is calculated using the share price and the number of shares on issue.

Share Information and Trading Details

Anatara Lifesciences Ltd has 315,950,765 shares on issue, with its share structure classified as ordinary fully paid shares. The company was listed on the Australian Securities Exchange on 16 October 2014.

The company’s bid and offer range was recorded at $0.009 - $0.010. The absence of recorded trading activity during the session meant there was no available daily price range.

The 52-week range of $0.007 to $0.020 provides a historical reference for the movement of the stock over the previous year. Such market statistics help readers understand the trading position of a Listed security at a specific point in time.

Healthcare Sector Context

Anatara Lifesciences Ltd is categorised within the healthcare sector. Companies within this sector may include businesses involved in healthcare-related activities, including biotechnology, pharmaceuticals and life sciences.

Individual share price movements can vary depending on company-specific developments, market participation and broader market conditions. A single Trading session reflects short-term market activity and does not represent the complete history of a company’s share performance.

Conclusion

In summary, Anatara Lifesciences Ltd (ASX:ANR) shares remained unchanged at $0.009 during the latest reported session, with no trading volume recorded. The company’s market capitalisation stood at $2.84M, with 315,950,765 shares on issue and a 52-week trading range of $0.007 to $0.020. The available trading information provides an educational overview of the company’s latest market position based on the supplied data.

Frequently Asked Questions (FAQs)

FAQs

Q: What was the share price of Anatara Lifesciences Ltd (ASX:ANR)?

A:Anatara Lifesciences Ltd (ASX:ANR) was trading at $0.009 based on the latest provided market data.

Q: Did ANR shares record any movement during the session?

A:No. The share price remained unchanged at $0.009, with a daily change of 0.000%.

Q: What was the trading volume for Anatara Lifesciences Ltd?

A:The trading volume was recorded at 0 shares during the session.

Q: What was the market capitalisation of Anatara Lifesciences Ltd?

A:The company’s market capitalisation was recorded at $2.84M based on the provided figures.

Q: What was the 52-week trading range for ASX:ANR?

A:The 52-week trading range was between $0.007 and $0.020.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.